Wed, Dec 17, 2014, 3:00 PM EST - U.S. Markets close in 1 hr.

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • dinepat203 dinepat203 Apr 26, 2014 10:58 AM Flag

    MKT CAP IS $2BILLIONS!!!! BUT - SRPT IS SLEEPING-OCT2007 - JAN2013- ONLY 12 PATIENTS

    CLINICALTRIALS.GOV

    1 Completed Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients

    Condition: Duchenne Muscular Dystrophy
    Intervention: Drug: AVI-4658 (Eteplirsen)
    ClinicalTrials.gov Identifier: NCT01396239
    First received: July 8, 2011
    Last updated: January 22, 2013
    Enrollment: 12
    Study Start Date: July 2011
    Study Completion Date: June 2012
    Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)


    2 Active, not recruiting Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy

    Condition: Duchenne Muscular Dystrophy
    Intervention: Drug: AVI-4658 (Eteplirsen)
    Enrollment: 12
    Study Start Date: February 2012
    Estimated Study Completion Date: July 2015
    Estimated Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)
    Enrollment: 19
    Study Start Date: January 2009
    Study Completion Date: December 2010
    Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)


    3 Completed Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients

    Condition: Duchenne Muscular Dystrophy
    Intervention: Drug: AVI-4658 for Injection
    Enrollment: 19
    Study Start Date: January 2009
    Study Completion Date: December 2010
    Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)


    4 Completed Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy

    Condition: Duchenne Muscular Dystrophy
    Intervention: Drug: AVI-4658 (PMO)
    Enrollment: 7
    Study Start Date: October 2007
    Study Completion Date: March 2009
    Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
13.29+0.69(+5.48%)2:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.